EV/EBITDA
N/A
8 min ago
Summary
- PACB EV/EBITDA is not available.
Performance
PACB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PACB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | - | +4.5% |
| 1 m1 month | - | - | +3.8% |
| 3 m3 months | - | - | -41.3% |
| 6 m6 months | - | - | -19.2% |
| ytdytd | - | - | -23.6% |
| 1 y1 year | - | - | -68.8% |
| 5 y5 years | - | - | -62.5% |
PACB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | -4.06 | -4.54 | ||
| 6 m | 6-month | -3.78 | -4.54 | ||
| 1 y | 1-year | -3.27 | -8.06 | ||
| 3 y | 3-year | -3.27 | -14.74 | ||
| 5 y | 5-year | 252.41 | -150.79 | ||
| alltime | all time | 252.41 | -150.79 |
Pacific Biosciences Of California EV/EBITDA History
| Date | Value |
|---|---|
| 2022 | -8.77(-56.2%) |
| 2021 | -20.02(-115.8%) |
| 2020 | 126.97(-1209.9%) |
| 2019 | -11.44(-4.0%) |
| 2018 | -11.92(+217.0%) |
| 2017 | -3.76(-28.1%) |
| Date | Value |
|---|---|
| 2016 | -5.23(-87.3%) |
| 2015 | -41.11(+335.9%) |
| 2014 | -9.43(+101.1%) |
| 2013 | -4.69(+694.9%) |
| 2012 | -0.59(-37.9%) |
| 2011 | -0.95(-81.6%) |
| 2010 | -5.16 |
FAQ
- What is the all time high EV/EBITDA for Pacific Biosciences of California?
What is the all time high EV/EBITDA for Pacific Biosciences of California?
Pacific Biosciences of California all-time high EV/EBITDA is 252.41